Shanghai - Delayed Quote CNY
Harbin Pharmaceutical Group Co., Ltd. (600664.SS)
3.7800
+0.0400
+(1.07%)
At close: May 23 at 3:00:03 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cash Flows from Used in Operating Activities Direct
598,724.6269
792,499.5643
949,670.9742
622,093.2014
-162,437.3815
Operating Cash Flow
--
792,499.5643
949,670.9742
622,093.2014
-162,437.3815
Investing Cash Flow
-101,740.5397
-98,914.9216
-206,644.0697
72,336.4526
91,615.4246
Financing Cash Flow
-522,997.8425
-125,605.6970
147,942.0773
174,616.6470
393,264.9952
End Cash Position
2,770,687.4175
3,526,357.6887
2,956,139.2551
2,064,246.3914
1,191,457.1920
Capital Expenditure
-105,964.7999
-100,813.8166
-86,535.4722
-89,645.5781
-76,696.3302
Issuance of Debt
1,810,849.4822
1,904,850.8651
3,207,013.6770
2,158,072.2778
1,856,887.7083
Repayment of Debt
-2,210,471.4562
-1,909,471.6303
-3,384,491.1937
-2,030,559.8098
-1,173,571.6243
Free Cash Flow
492,759.8271
691,685.7478
863,135.5020
532,447.6233
-239,133.7117
12/31/2021 - 6/29/1993
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade